Elaine Sorg is Senior Vice President, AbbVie and President, U.S. Commercial Operations. She leads the largest commercial area for the enterprise focused on advancing the commercial success of AbbVie’s full portfolio of brands in the United States, including immunology, oncology, specialty, neuroscience and eye care.
Ms. Sorg joined Abbott in 2012 as the Vice President of U.S. Immunology, a role she continued when AbbVie separated from Abbott in January 2013. Her responsibilities were expanded in 2016 as Vice President, Immunology and Oncology. In 2019, Ms. Sorg was named President, U.S. Immunology and AbbVie Patient Services. Prior to joining Abbott in 2012, Ms. Sorg served in management roles at Eli Lilly and Company for 23 years.
She currently serves on the Dean’s Advisory Board of the Purdue University College of Pharmacy and Pharmaceutical Sciences. She is a former member of the Biotechnology Innovation Organization (BIO) Health Section Governing Board and served on its Access and Value Committee and Regulatory Environment Committee from 2019-2022. Ms. Sorg also served as a member of the IBM Watson Health Advisory Board.
Ms. Sorg graduated from Purdue University School of Pharmacy and Pharmaceutical Sciences.